• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤浸润性CD8 + T细胞中的黏附缺陷。

Defective adhesion in tumor infiltrating CD8+ T cells.

作者信息

Koneru Mythili, Monu Ngozi, Schaer David, Barletta Justine, Frey Alan B

机构信息

Department of Cell Biology, and Kaplan Cancer Center, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.

出版信息

J Immunol. 2006 May 15;176(10):6103-11. doi: 10.4049/jimmunol.176.10.6103.

DOI:10.4049/jimmunol.176.10.6103
PMID:16670319
Abstract

CD8(+) tumor-infiltrating lymphocytes (TIL) are defective in cytolysis due to tumor-induced inhibition of proximal TCR-mediated signaling, a defect that is relieved upon purification and brief culture. We show in this study that frequency of conjugation in vitro of nonlytic TIL with tumor cells is low in comparison with their lytic counterparts, and the strength of interaction and duration of conjugation are also reduced. Previous reports show that p56(lck) activation is required for TCR-initiated LFA-1 avidity up-regulation, raising the question: is low LFA-1 avidity the basis of reduced TIL conjugation frequency? When stimulated with phorbol ester, nonlytic TIL bind purified ICAM-1 equivalently as lytic TIL, suggesting that LFA-1 can be activated if proximal TCR signaling is bypassed. However, when treated with phorbol ester, the conjugation frequency of nonlytic TIL does not increase. CD2 and CD8 also mediate T cell adhesion to cognate target cells and are both expressed at lower levels in nonlytic TIL in addition to being excluded from the immune synapse formed upon conjugation. Collectively, these results imply that adhesion defects in nonlytic TIL result from a combination of decreased cell surface levels of adhesion molecules, deficient LFA-1 activation, and the failure to recruit essential adhesion receptors to the membrane contact site formed with cognate target cells.

摘要

CD8(+)肿瘤浸润淋巴细胞(TIL)由于肿瘤诱导的近端TCR介导信号传导抑制而在细胞溶解方面存在缺陷,这种缺陷在纯化和短暂培养后可得到缓解。我们在本研究中表明,与具有细胞溶解能力的TIL相比,非细胞溶解型TIL与肿瘤细胞在体外的结合频率较低,并且相互作用强度和结合持续时间也降低。先前的报道表明,TCR启动的LFA-1亲和力上调需要p56(lck)激活,这就提出了一个问题:低LFA-1亲和力是否是TIL结合频率降低的基础?当用佛波酯刺激时,非细胞溶解型TIL与纯化的ICAM-1的结合能力与细胞溶解型TIL相当,这表明如果绕过近端TCR信号传导,LFA-1可以被激活。然而,当用佛波酯处理时,非细胞溶解型TIL的结合频率并未增加。CD2和CD8也介导T细胞与同源靶细胞的粘附,并且除了被排除在结合时形成的免疫突触之外,它们在非细胞溶解型TIL中的表达水平也较低。总体而言,这些结果表明,非细胞溶解型TIL中的粘附缺陷是由粘附分子细胞表面水平降低、LFA-1激活不足以及未能将必需的粘附受体募集到与同源靶细胞形成的膜接触位点共同导致的。

相似文献

1
Defective adhesion in tumor infiltrating CD8+ T cells.肿瘤浸润性CD8 + T细胞中的黏附缺陷。
J Immunol. 2006 May 15;176(10):6103-11. doi: 10.4049/jimmunol.176.10.6103.
2
Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells.CD8+肿瘤浸润性T细胞中近端T细胞受体信号传导和裂解功能的抑制
Cancer Res. 2007 Dec 1;67(23):11447-54. doi: 10.1158/0008-5472.CAN-07-1441.
3
Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function.有缺陷的近端TCR信号传导会抑制CD8 +肿瘤浸润淋巴细胞的裂解功能。
J Immunol. 2005 Feb 15;174(4):1830-40. doi: 10.4049/jimmunol.174.4.1830.
4
CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis.CD8(+)肿瘤浸润性T细胞由于微管组织中心动员缺陷和溶细胞颗粒胞吐作用而缺乏穿孔素介导的细胞溶解活性。
J Immunol. 2001 Nov 1;167(9):5042-51. doi: 10.4049/jimmunol.167.9.5042.
5
CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ.CD8 +肿瘤浸润淋巴细胞已准备好进行Fas介导的激活诱导的细胞死亡,但在原位并未凋亡。
J Immunol. 2001 May 15;166(10):6074-83. doi: 10.4049/jimmunol.166.10.6074.
6
The Inhibitory Signaling Receptor Protocadherin-18 Regulates Tumor-Infiltrating CD8 T-cell Function.抑制性信号受体原钙黏蛋白 18 调节肿瘤浸润 CD8+T 细胞功能。
Cancer Immunol Res. 2017 Oct;5(10):920-928. doi: 10.1158/2326-6066.CIR-17-0187. Epub 2017 Sep 5.
7
Treatment-enhanced CD4+Foxp3+ glucocorticoid-induced TNF receptor family related high regulatory tumor-infiltrating T cells limit the effectiveness of cytokine-based immunotherapy.治疗增强的CD4+Foxp3+糖皮质激素诱导的TNF受体家族相关高调节性肿瘤浸润T细胞限制了基于细胞因子的免疫疗法的有效性。
J Immunol. 2007 Mar 15;178(6):3400-8. doi: 10.4049/jimmunol.178.6.3400.
8
Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.在缺乏淋巴细胞功能相关抗原-1(LFA-1)的情况下,有缺陷的CD8 + T细胞活化和细胞溶解功能无法通过增加T细胞受体(TCR)信号传导来恢复。
J Immunol. 1999 Nov 1;163(9):4826-32.
9
Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity.在不依赖抗原特异性产生的小鼠肿瘤中缺陷性CD4-CD8-T细胞的特征分析。
J Immunol. 2004 Feb 1;172(3):1602-11. doi: 10.4049/jimmunol.172.3.1602.
10
Reconstitution of CD8+ T cells by retroviral transfer of the TCR alpha beta-chain genes isolated from a clonally expanded P815-infiltrating lymphocyte.通过逆转录病毒转移从克隆扩增的P815浸润淋巴细胞中分离的TCRαβ链基因来重建CD8 + T细胞。
J Immunol. 2003 Aug 15;171(4):2154-60. doi: 10.4049/jimmunol.171.4.2154.

引用本文的文献

1
and are potential targets of immunotherapy in non-small cell lung cancer.并且是非小细胞肺癌免疫治疗的潜在靶点。 (原句缺少主语,根据语境推测翻译,但严格来说原句表述不完整)
J Thorac Dis. 2025 Mar 31;17(3):1169-1184. doi: 10.21037/jtd-24-1589. Epub 2025 Mar 27.
2
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2.重新审视 T 细胞黏附分子作为癌症免疫治疗的潜在靶点:CD226 和 CD2。
Exp Mol Med. 2024 Oct;56(10):2113-2126. doi: 10.1038/s12276-024-01317-9. Epub 2024 Oct 1.
3
New insights into CAR T cell-mediated killing of tumor cells.
CAR T 细胞介导的杀伤肿瘤细胞的新见解。
Front Immunol. 2022 Sep 15;13:1016208. doi: 10.3389/fimmu.2022.1016208. eCollection 2022.
4
Immune Checkpoint Proteins, Metabolism and Adhesion Molecules: Overlooked Determinants of CAR T-Cell Migration?免疫检查点蛋白、代谢和黏附分子:CAR T 细胞迁移的被忽视决定因素?
Cells. 2022 Jun 6;11(11):1854. doi: 10.3390/cells11111854.
5
CD2-negative lymphoma-associated T-cells: a potential mechanism of immune-evasion in diffuse large B-cell lymphoma.CD2-阴性淋巴瘤相关 T 细胞:弥漫性大 B 细胞淋巴瘤免疫逃逸的潜在机制。
Virchows Arch. 2022 Oct;481(4):659-663. doi: 10.1007/s00428-022-03348-x. Epub 2022 May 27.
6
BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia.BET 溴结构域蛋白抑制逆转嵌合抗原受体耗竭并重新激活慢性淋巴细胞白血病中耗竭的 T 细胞。
J Clin Invest. 2021 Aug 16;131(16). doi: 10.1172/JCI145459.
7
Promises and challenges of adoptive T-cell therapies for solid tumours.过继性 T 细胞疗法治疗实体瘤的前景与挑战。
Br J Cancer. 2021 May;124(11):1759-1776. doi: 10.1038/s41416-021-01353-6. Epub 2021 Mar 29.
8
PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and target tumor cells within the tumor.PD-1 抑制细胞毒性 T 细胞和肿瘤内靶肿瘤细胞之间细胞对的维持。
Sci Signal. 2020 Sep 15;13(649):eaau4518. doi: 10.1126/scisignal.aau4518.
9
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals.免疫突触外缘富含 CD2 的动态隔室增强和整合信号。
Nat Immunol. 2020 Oct;21(10):1232-1243. doi: 10.1038/s41590-020-0770-x. Epub 2020 Sep 14.
10
Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer.MUC1 mRNA 纳米疫苗联合 CTLA-4 阻断的免疫治疗有效抑制三阴性乳腺癌的生长。
Mol Ther. 2018 Jan 3;26(1):45-55. doi: 10.1016/j.ymthe.2017.10.020. Epub 2017 Dec 5.